PL2842563T3 - Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym - Google Patents

Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym

Info

Publication number: PL2842563T3
Authority: PL; Poland
Prior art keywords: treating; composition; eggshell membrane; diabetic mammals; powdered eggshell
Prior art date: 2010-04-12

Application number

PL14182072.0T

Other languages

English (en)

Inventor

Kevin Ruff

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-04-12

Filing date

2011-04-12

Publication date

2016-12-30

2011-04-12 Application filed filed Critical

2016-12-30 Publication of PL2842563T3 publication Critical patent/PL2842563T3/pl

Links

206010018429 Glucose tolerance impaired Diseases 0.000 title 1
241000124008 Mammalia Species 0.000 title 1
229940012466 egg shell membrane Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

PL14182072.0T 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym PL2842563T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US32330310P	2010-04-12	2010-04-12

Publications (1)

Publication Number	Publication Date
PL2842563T3 true PL2842563T3 (pl)	2016-12-30

Family

ID=44798988

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL14182072.0T PL2842563T3 (pl)	2010-04-12	2011-04-12	Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym
PL11769433T PL2557920T3 (pl)	2010-04-12	2011-04-12	Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL11769433T PL2557920T3 (pl)	2010-04-12	2011-04-12	Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy

Country Status (13)

Country	Link
US (2)	US8679551B2 (pl)
EP (2)	EP2842563B1 (pl)
CN (2)	CN103002736B (pl)
AU (1)	AU2011240764B2 (pl)
CA (1)	CA2796336C (pl)
CY (2)	CY1116808T1 (pl)
ES (2)	ES2579340T3 (pl)
MX (1)	MX2012011881A (pl)
NZ (1)	NZ602949A (pl)
PL (2)	PL2842563T3 (pl)
PT (2)	PT2842563T (pl)
RS (2)	RS55025B1 (pl)
WO (1)	WO2011130261A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2440390B1 (es) *	2012-07-25	2014-11-13	Bioibérica, S.A.	Composiciones para el tratamiento del sobrepeso y de la obesidad
JP5998350B2 (ja) *	2013-03-27	2016-09-28	国立大学法人東京大学	卵殻膜成分を含む肝保護剤ならびにそれを用いた医薬組成物、食品添加物および食品
JP2014231487A (ja) *	2013-05-28	2014-12-11	国立大学法人東京大学	卵殻膜成分を含むサーチュイン遺伝子活性化剤ならびにそれを用いた組成物
US20140363519A1 (en) *	2013-06-11	2014-12-11	The University Of Tokyo	Activator of gene expression of molecular chaperone gene comprising eggshell membrane component and composition thereof
US11478504B2 (en)	2013-07-08	2022-10-25	International Dehydrated Foods, Inc.	Compositions and methods for preventing/treating metabolic syndrome
MX375862B (es) *	2013-07-08	2025-03-07	Int Dehydrated Foods Inc	Composiciones preparadas de aves de corral y metodos de su uso.
JP6056064B2 (ja) *	2013-11-29	2017-01-11	国立大学法人東京大学	卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物
CN118272477B (zh) *	2024-04-25	2025-01-10	华中农业大学	用于降血糖的蛋壳膜水解物、肽及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5652221A (en) *	1994-11-07	1997-07-29	The University Of Virginia Patent Foundation	Method of treating defective glucose metabolism using synthetic insulin substances
GB0213612D0 (en) *	2002-06-13	2002-07-24	Novartis Nutrition Ag	Organic compounds
DE20213669U1 (de) *	2002-09-02	2004-02-12	Ewald Speth Antriebstechnik Gmbh	Direkt angetriebene Antriebsachse mit einer an axial festgelegtes Sonnenritzel aufweisenden Getriebestufe
US20080063677A1 (en) *	2004-03-10	2008-03-13	New Life Resources, Llc	Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
KR100662903B1 (ko) *	2004-12-14	2007-01-02	건국대학교 산학협력단	글루코사민 하이드로클로라이드를 함유하는 당뇨 질환치료용 의약 조성물
CA2556343A1 (en) *	2005-09-01	2007-03-01	Purepharm Inc.	Synthetic nutritional formulations
JP2012518617A (ja) *	2009-02-23	2012-08-16	ディーエスエムアイピーアセッツビー．ブイ．	炎症性疾患のためのキマメ（Ｃａｊａｎｕｓ）抽出物およびグルコサミン

2011
- 2011-04-12 NZ NZ602949A patent/NZ602949A/en unknown
- 2011-04-12 EP EP14182072.0A patent/EP2842563B1/en active Active
- 2011-04-12 PT PT141820720T patent/PT2842563T/pt unknown
- 2011-04-12 AU AU2011240764A patent/AU2011240764B2/en active Active
- 2011-04-12 CN CN201180029018.9A patent/CN103002736B/zh active Active
- 2011-04-12 ES ES14182072.0T patent/ES2579340T3/es active Active
- 2011-04-12 MX MX2012011881A patent/MX2012011881A/es unknown
- 2011-04-12 RS RS20160484A patent/RS55025B1/sr unknown
- 2011-04-12 RS RS20150051A patent/RS53826B1/sr unknown
- 2011-04-12 ES ES11769433.1T patent/ES2528413T3/es active Active
- 2011-04-12 PT PT117694331T patent/PT2557920E/pt unknown
- 2011-04-12 CN CN201510567716.4A patent/CN105250335B/zh active Active
- 2011-04-12 PL PL14182072.0T patent/PL2842563T3/pl unknown
- 2011-04-12 PL PL11769433T patent/PL2557920T3/pl unknown
- 2011-04-12 WO PCT/US2011/032103 patent/WO2011130261A1/en not_active Ceased
- 2011-04-12 CA CA2796336A patent/CA2796336C/en active Active
- 2011-04-12 EP EP11769433.1A patent/EP2557920B1/en active Active
- 2011-04-12 US US13/640,607 patent/US8679551B2/en active Active
2014
- 2014-03-13 US US14/209,214 patent/US8927032B2/en active Active
2015
- 2015-01-19 CY CY20151100052T patent/CY1116808T1/el unknown
2016
- 2016-06-30 CY CY20161100599T patent/CY1117799T1/el unknown

Also Published As

Publication number	Publication date
US20140193516A1 (en)	2014-07-10
CY1117799T1 (el)	2017-05-17
EP2557920A4 (en)	2013-10-23
CN103002736B (zh)	2015-11-25
US8927032B2 (en)	2015-01-06
EP2842563A1 (en)	2015-03-04
RS53826B1 (sr)	2015-06-30
ES2579340T3 (es)	2016-08-10
CN105250335B (zh)	2019-10-29
EP2557920B1 (en)	2014-11-12
US20130089619A1 (en)	2013-04-11
CA2796336C (en)	2018-06-05
EP2842563B1 (en)	2016-05-25
US8679551B2 (en)	2014-03-25
CA2796336A1 (en)	2011-10-20
CN105250335A (zh)	2016-01-20
ES2528413T3 (es)	2015-02-10
NZ602949A (en)	2014-11-28
EP2557920A1 (en)	2013-02-20
MX2012011881A (es)	2013-04-19
PT2557920E (pt)	2015-02-05
CY1116808T1 (el)	2017-03-15
WO2011130261A1 (en)	2011-10-20
PL2557920T3 (pl)	2015-04-30
PT2842563T (pt)	2016-07-14
RS55025B1 (sr)	2016-11-30
CN103002736A (zh)	2013-03-27
AU2011240764A1 (en)	2012-11-08
AU2011240764B2 (en)	2014-07-10

Publication	Publication Date	Title
GB201002983D0 (en)	2010-04-07	Nutritinal composition
GB201006699D0 (en)	2010-06-09	Composition
GB201021186D0 (en)	2011-01-26	Composition
ZA201302113B (en)	2014-05-28	Caspofungin composition
PL2842563T3 (pl)	2016-12-30	Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym
GB201006178D0 (en)	2010-06-02	Composition
GB201010374D0 (en)	2010-08-04	Disinfectant composition
GB201021269D0 (en)	2011-01-26	Composition
GB201017048D0 (en)	2010-11-24	Composition
GB201016970D0 (en)	2010-11-24	Composition
PL2534302T3 (pl)	2020-10-19	Kompozycja do obróbki powierzchni
PL2625258T3 (pl)	2019-05-31	Kompozycja do czyszczenia z polimerów
GB201019988D0 (en)	2011-01-05	Composition
GB201007531D0 (en)	2010-06-23	Composition
GB201006214D0 (en)	2010-06-02	Composition
GB201018083D0 (en)	2010-12-08	Absorbant Composition
GB201006204D0 (en)	2010-06-02	Composition
GB201004717D0 (en)	2010-05-05	Composition
GB201014967D0 (en)	2010-10-20	Composition
GB201010657D0 (en)	2010-08-11	Composition
PL2534235T3 (pl)	2014-03-31	Kompozycja
GB201018130D0 (en)	2010-12-08	Composition
GB201006175D0 (en)	2010-06-02	Composition
GB201006182D0 (en)	2010-06-02	Composition
GB201006012D0 (en)	2010-05-26	Composition